ARTICLE | Company News
Evec, Astellas in infectious disease deal
September 7, 2011 12:59 AM UTC
Evec Inc. (Sapporo, Japan) granted Astellas Pharma Inc. (Tokyo:4503) exclusive, worldwide rights to develop and commercialize one of Evec's preclinical antibodies against infectious diseases. Evec wil...